{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:05:43Z","timestamp":1757451943860},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.intimp.2013.07.024","type":"journal-article","created":{"date-parts":[[2013,8,20]],"date-time":"2013-08-20T07:15:10Z","timestamp":1376982910000},"page":"519-525","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Influences of cerebral stent implantation on CD4+CD25+FOXP3+Treg, Th1 and Th17 cells"],"prefix":"10.1016","volume":"17","author":[{"given":"Sijia","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shugui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2013.07.024_bb0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2013.07.024_bb0010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1161\/01.ATV.9.5.567","article-title":"Immune mechanisms in atherosclerosis","volume":"9","author":"Hansson","year":"1989","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.intimp.2013.07.024_bb0015","first-page":"273","article-title":"Cherry pip bezoars causing acute small intestinal obstruction presenting as diabetic ketoacidosis","volume":"24","author":"Alexander","year":"2005","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.intimp.2013.07.024_bb0020","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.07.024_bb0025","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2013.07.024_bb0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.intimp.2013.07.024_bb0035","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nri1488","article-title":"Forkhead-box transcription factors and their role in the immune system","volume":"4","author":"Coffer","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.intimp.2013.07.024_bb0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2013.07.024_bb0045","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2741\/2667","article-title":"Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity","volume":"13","author":"Yu","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.intimp.2013.07.024_bb0050","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaut.2008.04.017","article-title":"Role of Th1 and Th17 cells in organ-specific autoimmunity","volume":"31","author":"Dardalhon","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.intimp.2013.07.024_bb0055","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1093\/eurheartj\/ehl222","article-title":"Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes","volume":"27","author":"Mor","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.intimp.2013.07.024_bb0060","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.thromres.2006.12.005","article-title":"Frequency of naturally-occurring regulatory T cells is reduced in patients with ST-segment elevation myocardial infarction","volume":"120","author":"Sardella","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.intimp.2013.07.024_bb0065","first-page":"356","article-title":"The significance of high sensitive C reactive protein as a risk factor for cardiovascular diseases","volume":"60","author":"Meguro","year":"2012","journal-title":"Rinsho Byori"},{"key":"10.1016\/j.intimp.2013.07.024_bb0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2217\/bmm.11.108","article-title":"High-sensitive C-reactive protein: universal prognostic and causative biomarker in heart disease?","volume":"6","author":"Rietzschel","year":"2012","journal-title":"Biomark Med"},{"key":"10.1016\/j.intimp.2013.07.024_bb0075","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1212\/WNL.55.7.952","article-title":"Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial","volume":"55","author":"Frankel","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2013.07.024_bb0080","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1161\/01.STR.27.10.1817","article-title":"Comparison of neurological scales and scoring systems for acute stroke prognosis","volume":"27","author":"Muir","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.intimp.2013.07.024_bb0085","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/PHM.0b013e31813e0a32","article-title":"Lesion characteristics, NIH stroke scale, and functional recovery after stroke","volume":"86","author":"Glymour","year":"2007","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.intimp.2013.07.024_bb0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejvs.2011.01.001","article-title":"Carotid Stenting Trialists C. Age modifies the relative risk of stenting versus endarterectomy for symptomatic carotid stenosis\u2014a pooled analysis of EVA-3S, SPACE and ICSS","volume":"41","author":"Bonati","year":"2011","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.intimp.2013.07.024_bb0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0912321","article-title":"Stenting versus endarterectomy for treatment of carotid-artery stenosis","volume":"363","author":"Brott","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2013.07.024_bb0100","doi-asserted-by":"crossref","first-page":"65L","DOI":"10.1016\/j.amjcard.2005.09.064","article-title":"Coronary stenting and inflammation","volume":"96","author":"Gaspardone","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.intimp.2013.07.024_bb0105","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/path.2667","article-title":"Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques","volume":"220","author":"de Boer","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.intimp.2013.07.024_bb0110","first-page":"S71","article-title":"Th17 cells in Behcet's disease: a new immunoregulatory axis","volume":"29","author":"Hamzaoui","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.intimp.2013.07.024_bb0115","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1182\/blood-2010-11-317321","article-title":"Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells","volume":"117","author":"Hoechst","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2013.07.024_bb0120","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/eji.201040682","article-title":"Human tumor-infiltrating Th17 cells have the capacity to differentiate into IFN-gamma+ and FOXP3+ T cells with potent suppressive function","volume":"41","author":"Ye","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.intimp.2013.07.024_bb0125","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.CIR.99.1.44","article-title":"Pathology of acute and chronic coronary stenting in humans","volume":"99","author":"Farb","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2013.07.024_bb0130","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.smim.2011.04.003","article-title":"Making sense of regulatory T cell suppressive function","volume":"23","author":"Shalev","year":"2011","journal-title":"Semin Immunol"},{"key":"10.1016\/j.intimp.2013.07.024_bb0135","doi-asserted-by":"crossref","first-page":"503","DOI":"10.5551\/jat.10934","article-title":"Regulatory T cells in atherogenesis","volume":"19","author":"Sasaki","year":"2012","journal-title":"J Atheroscler Thromb"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913003111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913003111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T23:25:17Z","timestamp":1688426717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576913003111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1567576913003111"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2013.07.024","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influences of cerebral stent implantation on CD4+CD25+FOXP3+Treg, Th1 and Th17 cells","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2013.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}